Structure of Human GIVD Cytosolic Phospholipase A2 Reveals Insights into Substrate Recognition

被引:9
|
作者
Wang, Hui [1 ]
Klein, Michael G. [1 ]
Snell, Gyorgy [1 ]
Lane, Weston [1 ]
Zou, Hua [1 ]
Levin, Irena [1 ]
Li, Ke [1 ]
Sang, Bi-Ching [1 ]
机构
[1] Takeda Calif, Dept Biol Struct, San Diego, CA 92121 USA
基金
美国国家卫生研究院;
关键词
cPLA(2); alpha/beta hydrolase; inhibitor; C2; domain; calcium binding; ARACHIDONIC-ACID; C2; DOMAIN; CRYSTAL-STRUCTURE; INHIBITORS; MEMBRANE; MECHANISM; TOPOLOGY; DISEASE; ENZYMES; SYSTEM;
D O I
10.1016/j.jmb.2016.05.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytosolic phospholipases A(2) (cPLA(2)s) consist of a family of calcium-sensitive enzymes that function to generate lipid second messengers through hydrolysis of membrane-associated glycerophospholipids. The GIVD cPLA(2) (cPLA(2)delta) is a potential drug target for developing a selective therapeutic agent for the treatment of psoriasis. Here, we present two X-ray structures of human cPLA(2)delta, capturing an apo state, and in complex with a substrate-like inhibitor. Comparison of the apo and inhibitor-bound structures reveals conformational changes in a flexible cap that allows the substrate to access the relatively buried active site, providing new insight into the mechanism for substrate recognition. The cPLA(2)delta structure reveals an unexpected second C2 domain that was previously unrecognized from sequence alignments, placing cPLA(2)delta into the class of membrane-associated proteins that contain a tandem pair of C2 domains. Furthermore, our structures elucidate novel inter-domain interactions and define three potential calcium-binding sites that are likely important for regulation and activation of enzymatic activity. These findings provide novel insights into the molecular mechanisms governing cPLA(2)'s function in signal transduction. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2769 / 2779
页数:11
相关论文
共 50 条
  • [41] Regulation of cytosolic phospholipase A2 activity by sphingolipids
    Shimizu, M
    Matsumoto, Y
    Hirabayashi, T
    Murayama, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 144P - 144P
  • [42] Cytosolic phospholipase A2 as a target for drug design
    Lehr, M
    DRUGS OF THE FUTURE, 2000, 25 (08) : 823 - 832
  • [43] Cytosolic phospholipase A2 as a mediator of disease pathogenesis
    Linkous, Amanda
    Yazlovitskaya, Eugenia
    CELLULAR MICROBIOLOGY, 2010, 12 (10) : 1369 - 1377
  • [44] The role of cytosolic phospholipase A2 in insulin secretion
    Jones, PM
    Burns, CJ
    Belin, VD
    Roderigo-Milne, HM
    Persaud, SJ
    DIABETES, 2004, 53 : S172 - S178
  • [45] Increased levels of cytosolic phospholipase A2 in dyslexics
    MacDonnell, LEF
    Skinner, FK
    Eward, PE
    Glen, AIM
    Glen, ACA
    Macdonald, DJ
    Boyle, RM
    Horrobin, DF
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2000, 63 (1-2): : 37 - 39
  • [46] Nuclear membrane mechanotransduction by cytosolic phospholipase A2
    Niethammer, P.
    Shen, Z.
    Belcheva, K. T.
    Jelcic, M.
    Hui, K.
    Katikaneni, A.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 99 - 99
  • [47] Recent advances in the regulation of cytosolic phospholipase A2
    Gijon, MA
    Spencer, DM
    Leslie, CC
    ADVANCES IN ENZYME REGULATION, VOL 40, 2000, 40 : 255 - 268
  • [48] Cytosolic Phospholipase A2: A Drug Target in FSGS
    Erkan, Elif
    Chhaing, Richard
    Potter, Andrew
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 50 - 51
  • [49] Cytosolic Phospholipase A2 and Lysophospholipids in Tumor Angiogenesis
    Linkous, Amanda G.
    Yazlovitskaya, Eugenia M.
    Hallahan, Dennis E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (18): : 1398 - 1412
  • [50] Solution structure and membrane interactions of the C2 domain of cytosolic phospholipase A2
    Xu, GY
    McDonagh, T
    Yu, HA
    Nalefski, EA
    Clark, JD
    Cumming, DA
    JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (03) : 485 - 500